© 1997 American Heart Association, Inc.
Articles |
Importance of Estrogen Receptors in Hepatic LDL Receptor Regulation
From the Metabolism Unit, Center for Metabolism and Endocrinology, Department of Medicine, and the Molecular Nutrition Unit, Center for Nutrition and Toxicology, Novum, Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden.
Correspondence to Mats Rudling, MD, Molecular Nutrition Unit, Center for Nutrition and Toxicology, Novum, S-141 57 Huddinge, Sweden. E-mail mats.rudling{at}cnt.ki.se.
Abstract Treatment with pharmacological doses of estrogen is the most potent way to stimulate hepatic LDL receptor expression in vivo. The mechanism for this effect is unclear, in part because of difficulties in inducing this stimulation in vitro. A fundamental question, whether estrogen receptors (ERs) mediate this stimulation, has not been addressed. The aim of the current study was to determine the involvement of ERs in the estrogen-induced stimulation of LDL receptors. Treatment of rats with high doses of ethynylestradiol for 7 days increased the hepatic LDL receptor protein and mRNA levels four- and threefold, respectively. LDL receptor stimulation in estrogen-treated rats was not due to their reduced food intake because hepatic LDL receptor expression did not increase in rats fasted for 72 hours. Treatment with antiestrogen (tamoxifen or clomiphene) abolished the LDL receptor stimulatory effect of ethynylestradiol at both the protein and mRNA levels. Antiestrogen alone had no effect on hepatic LDL receptor expression and did not influence the strong resistance to dietary cholesterol normally present in rats. It is concluded that ERs are critically involved in the induction of hepatic LDL receptor expression by ethynylestradiol. The known role of growth hormone for the expression of hepatic ERs may therefore play a role in the modulation of the effects of estrogen on cholesterol metabolism and hepatic LDL receptors in the rat.
Key Words: estrogen receptor • fasting • growth hormone • LDL receptor • mRNA
This article has been cited by other articles:
 |
|
 |
|
  L. A. Henriquez-Hernandez, A. Flores-Morales, R. Santana-Farre, M. Axelson, P. Nilsson, G. Norstedt, and L. Fernandez-Perez Role of Pituitary Hormones on 17{alpha}-Ethinylestradiol-Induced Cholestasis in Rat J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 695 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yura, M. Ishihara, Y. Kanatani, B. Takase, H. Hattori, S. Suzuki, M. Kawakami, and T. Matsui Interaction Study between Synthetic Glycoconjugate Ligands and Endocytic Receptors Using Flow Cytometry. J. Biochem., April 1, 2006; 139(4): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Johansson, M. Rudling, T. S. Scanlan, T. Lundasen, P. Webb, J. Baxter, B. Angelin, and P. Parini Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice PNAS, July 19, 2005; 102(29): 10297 - 10302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lemieux, Y. Gelinas, J. Lalonde, F. Labrie, K. Cianflone, and Y. Deshaies Hypolipidemic action of the SERM acolbifene is associated with decreased liver MTP and increased SR-BI and LDL receptors J. Lipid Res., June 1, 2005; 46(6): 1285 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suarez, C. Fernandez, D. Gomez-Coronado, A. J. Ferruelo, A. Davalos, J. Martinez-Botas, and M. A. Lasuncion Synergistic upregulation of low-density lipoprotein receptor activity by tamoxifen and lovastatin Cardiovasc Res, November 1, 2004; 64(2): 346 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Hewitt, W. C. Boon, Y. Murata, M. E. E. Jones, and E. R. Simpson The Aromatase Knockout Mouse Presents with a Sexually Dimorphic Disruption to Cholesterol Homeostasis Endocrinology, September 1, 2003; 144(9): 3895 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Liu, F. Zhang, C. Li, M. Lin, and M. R. Briggs Synergistic Activation of Human LDL Receptor Expression by SCAP Ligand and Cytokine Oncostatin M Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 90 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Wilcox, N. M. Borradaile, L. E. de Dreu, and M. W. Huff Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP J. Lipid Res., May 1, 2001; 42(5): 725 - 734. [Abstract] [Full Text]
|
|
|
|
|
|
C. Li, M. R. Briggs, T. E. Ahlborn, F. B. Kraemer, and J. Liu Requirement of Sp1 and Estrogen Receptor {{alpha}} Interaction in 17{beta}-Estradiol-Mediated Transcriptional Activation of the Low Density Lipoprotein Receptor Gene Expression Endocrinology, April 1, 2001; 142(4): 1546 - 1553. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R Holmer, C. Hengstenberg, B. Mayer, A. Doring, H. Lowel, S. Engel, H.-W. Hense, M. Wolf, G. Klein, G. A.J Riegger, et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population Cardiovasc Res, September 1, 2000; 47(4): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Parini, B. Angelin, A. Stavreus-Evers, B. Freyschuss, H. Eriksson, and M. Rudling Biphasic Effects of the Natural Estrogen 17{beta}-Estradiol on Hepatic Cholesterol Metabolism in Intact Female Rats Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1817 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Karjalainen, J. Heikkinen, M. J. Savolainen, A.-C. Backstrom, and Y. A. Kesaniemi Mechanisms Regulating LDL Metabolism in Subjects on Peroral and Transdermal Estrogen Replacement Therapy Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1101 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Parini, B. Angelin, and M. Rudling Cholesterol and Lipoprotein Metabolism in Aging : Reversal of Hypercholesterolemia by Growth Hormone Treatment in Old Rats Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 832 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Santanam, R. Shern-Brewer, R. McClatchey, P. Z. Castellano, A. A. Murphy, S. Voelkel, and S. Parthasarathy Estradiol as an antioxidant: incompatible with its physiological concentrations and function J. Lipid Res., November 1, 1998; 39(11): 2111 - 2118. [Abstract] [Full Text]
|
|